<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05092490</url>
  </required_header>
  <id_info>
    <org_study_id>1723038-1</org_study_id>
    <nct_id>NCT05092490</nct_id>
  </id_info>
  <brief_title>Serratus Anterior Plane Block Combined With Transversus Thoracic Muscle Plane Block Versus Conventional Local Anesthetic Infiltration for SICD Implantation: A Randomized Controlled Trial</brief_title>
  <official_title>Serratus Anterior Plane Block Combined With Transversus Thoracic Muscle Plane Block Versus Conventional Local Anesthetic Infiltration for SICD Implantation: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York Presbyterian Brooklyn Methodist Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York Presbyterian Brooklyn Methodist Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized study. The aim is to investigate the efficacy of a combined&#xD;
      SAPB with TTPB for perioperative pain control compared to the standard local anesthetic&#xD;
      infiltration technique in adult patients undergoing SICD implantation. The hypothesis is that&#xD;
      the combined plane block provides better pain control compared to the standard local&#xD;
      infiltration technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2021</start_date>
  <completion_date type="Anticipated">February 24, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 24, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Participants are not informed about which block they are receiving&#xD;
1 study personnel assess the pain scores and patient satisfaction postoperative</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain score measured</measure>
    <time_frame>1 day</time_frame>
    <description>by Numerical Rating Scale pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative pain score measured</measure>
    <time_frame>Intraoperative</time_frame>
    <description>by Numerical Rating Scale pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative sedation score</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Ramsy sedation scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total local anesthetic volume used</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Total local anesthetic volume used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure duration</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Procedure duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative hemodynamics</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Intraoperative hemodynamics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to 1st rescue pain medication</measure>
    <time_frame>1 day</time_frame>
    <description>Time to 1st rescue pain medication after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>1 day</time_frame>
    <description>Amount of opioids consumed after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 day</time_frame>
    <description>How much is the patient satisfied with the pain management in the perioperative period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block related complications</measure>
    <time_frame>1 day</time_frame>
    <description>Any complications that may happen from either blocks, e.g infection, bleeding</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Efficacy of Combined SAPB With TTPB for Perioperative Pain Control Compared to Local Infiltration in Patients Undergoing SICD Implantation</condition>
  <arm_group>
    <arm_group_label>Combined serratus anterior plane block and transversus thoracis plane block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group will receive a combined plane block by a dedicated anesthesia team prior to their procedure. 20 mL of local anesthetic (0.25% bupivacaine) will be injected for the Serratus anterior plane block and another 20 mL of local anesthetic (0.25% bupivacaine) will be injected in transversus thoracis plane block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stand local anesthetic infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local anesthetic infiltration of the incision sites will be performed by the cardiologist prior to, and as, necessary during the procedure. The amount of local anesthetic used will be determined intraoperatively by the cardiologist according to the patients' requirements.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined serratus anterior plane block and transversus thoracis plane block</intervention_name>
    <description>The study group will receive a combined plane block by a dedicated anesthesia team prior to their procedure. 20 mL of local anesthetic (0.25% bupivacaine) will be injected for the Serratus anterior plane block and another 20 mL of local anesthetic (0.25% bupivacaine) will be injected in transversus thoracis plane block</description>
    <arm_group_label>Combined serratus anterior plane block and transversus thoracis plane block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard local infiltration technique</intervention_name>
    <description>Local anesthetic infiltration of the incision sites will be performed by the cardiologist prior to, and as, necessary during the procedure. The amount of local anesthetic used will be determined intraoperatively by the cardiologist according to the patients' requirements.</description>
    <arm_group_label>Stand local anesthetic infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is able to provide a written informed consent.&#xD;
&#xD;
          -  Patient is scheduled to have an elective SICD implantation procedure.&#xD;
&#xD;
          -  Patient has none of the exclusion criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is unable to provide a written informed consent.&#xD;
&#xD;
          -  Patient is younger than 18 years old.&#xD;
&#xD;
          -  Patients with prior thoracotomy or other thoracic surgery altering anatomy.&#xD;
&#xD;
          -  Patients with neurological deficits.&#xD;
&#xD;
          -  Patients with impaired coagulation (Platelet count &lt; 50,000 cells/mcl and/or INR &gt;&#xD;
             1.4).&#xD;
&#xD;
          -  Patient on anticoagulation therapy.&#xD;
&#xD;
          -  Patient's weight below 50 kg&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Chen Kon, BS</last_name>
      <phone>917-655-1288</phone>
      <email>roc9218@nyp.org</email>
    </contact>
    <contact_backup>
      <last_name>Joel Yarmush, MD, MPA</last_name>
      <phone>973-666-0136</phone>
      <email>joelyarmush@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Joel Yarmush, MD,MPA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, Knops RE, Weiss R, Leon AR, Herre JM, Husby M, Stein KM, Lambiase PD. Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.</citation>
    <PMID>25908064</PMID>
  </results_reference>
  <results_reference>
    <citation>Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013 Aug 27;128(9):944-53. doi: 10.1161/CIRCULATIONAHA.113.003042.</citation>
    <PMID>23979626</PMID>
  </results_reference>
  <results_reference>
    <citation>Essandoh MK, Otey AJ, Abdel-Rasoul M, Stein EJ, Turner KR, Joseph NC, Daoud EG. Monitored Anesthesia Care for Subcutaneous Cardioverter-Defibrillator Implantation: A Single-Center Experience. J Cardiothorac Vasc Anesth. 2016 Oct;30(5):1228-33. doi: 10.1053/j.jvca.2016.06.007. Epub 2016 Jun 8.</citation>
    <PMID>27640893</PMID>
  </results_reference>
  <results_reference>
    <citation>Afzal MR, Okabe T, Koppert T, Tyler J, Houmsse M, Augostini RS, Hummel JD, Kalbfleisch SJ, Iyer MH, Flores AS, Bhandary S, Dimitrova G, Elsayed-Awad H, Fiorini K, Gorelik L, Perez W, Saklayen S, Stein E, Turner K, Franklin NP, Ryu JN, Bhatt A, Weiss R, Daoud EG, Essandoh M. Implantation of subcutaneous defibrillator is feasible and safe with monitored anesthesia care. Pacing Clin Electrophysiol. 2019 Dec;42(12):1552-1557. doi: 10.1111/pace.13838. Epub 2019 Nov 18.</citation>
    <PMID>31702059</PMID>
  </results_reference>
  <results_reference>
    <citation>Ziacchi M, Bisignani G, Palmisano P, Scalone A, Martignani C, Elvira Mocavero P, Caravati F, Della Cioppa N, Mazzuero A, Pecora D, Vicentini A, Landolina ME, Debonis S, Scimia P, Lovecchio M, Valsecchi S, Diemberger I, Droghetti A. Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: A case-control analysis. J Cardiovasc Electrophysiol. 2020 Jan;31(1):144-149. doi: 10.1111/jce.14293. Epub 2019 Dec 3.</citation>
    <PMID>31778266</PMID>
  </results_reference>
  <results_reference>
    <citation>Miller MA, Garg J, Salter B, Brouwer TF, Mittnacht AJ, Montgomery ML, Honikman R, Arkonac DE, Choudry S, Dukkipati SR, Reddy VY, Weiner MM. Feasibility of subcutaneous implantable cardioverter-defibrillator implantation with opioid sparing truncal plane blocks and deep sedation. J Cardiovasc Electrophysiol. 2019 Jan;30(1):141-148. doi: 10.1111/jce.13750. Epub 2018 Oct 22.</citation>
    <PMID>30230098</PMID>
  </results_reference>
  <results_reference>
    <citation>Uran C, Giojelli A, Borgogna DA, Morello G, Marullo F, Iodice P, Greco A, Accogli M, Guido A, Palmisano P. Ultrasound-guided serratus anterior plane block combined with parasternal block in subcutaneous implantable cardioverter defibrillator implantation: Results of a pilot study. Pacing Clin Electrophysiol. 2020 Jul;43(7):705-712. doi: 10.1111/pace.13944. Epub 2020 Jun 3.</citation>
    <PMID>32420626</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>October 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York Presbyterian Brooklyn Methodist Hospital</investigator_affiliation>
    <investigator_full_name>Joel Yarmush</investigator_full_name>
    <investigator_title>MD, MPA</investigator_title>
  </responsible_party>
  <keyword>Serratus anterior plane block</keyword>
  <keyword>Transversus thoracis plane block</keyword>
  <keyword>SICD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

